Ten ways in which He Jiankui violated ethics

  title={Ten ways in which He Jiankui violated ethics},
  author={Sheldon Krimsky},
  journal={Nature Biotechnology},
  • S. Krimsky
  • Published 1 January 2019
  • Psychology, Medicine
  • Nature Biotechnology
1. Roskams-Edris, D., Anderson-Redick, S., Kiss, Z.H. & Illes, J. Nat. Biotechnol. 35, 119–121 (2017). 2. Foster, A.M. et al. US patent 9,327,069 (2006). 3. Wagner, T.A. et al. US patent 9,050,463 (2015). 4. Krueger, R. & Weiss, D. US patent 9,283,378 (2012). 5. Association for Molecular Pathology v. Myriad Genetics, Inc. 569 U.S. 576 (2013). 6. 35 U.S. Code §287(c). 7. United States Constitution, Article I, Section 8, Clause 8. 8. Bonito Boats, Inc. v. Thunder Craft Boats, Inc. 489 U.S. 141… 

Topics from this paper

Governance of Emerging Biotechnologies: Lessons from Two Chinese Cases
  • Hui Zhang, Cuilian Zhang, +4 authors Yuming Wang
  • Medicine
    The American journal of bioethics : AJOB
  • 2022
A reflexive, anticipatory, and deliberative approach to unanticipated discoveries: Ethical lessons from IBlastoids, and a framework for responsible innovation.
CRISPR-Cas9 and He Jiankui's Case: an Islamic Bioethics Review using Maqasid al-Shari'a and Qawaid Fighiyyah.
It is argued that from an Islamic standpoint, the therapeutic application of CRISPR-Cas9 for germline editing may be permissible if the safety and efficacy concerns are resolved and if the principles of Maqasid al-Shari'a are fulfilled.
Germline Genome Editing Research: What Are Gamete Donors (Not) Informed About in Consent Forms?
The analysis of informed consent forms for egg and sperm donation used in a widely publicized study where genome editing was used to correct a disease-causing genetic mutation in human embryos indicates deficiencies in how the forms addressed various issues.
Reexamining the Ethics of Human Germline Editing in the Wake of Scandal.
The editing of the human germline for reproductive purposes should be understood against an historic backdrop of clinical research in assisted reproduction, as well as other exemplars of translational investigation, and how to understand the implicit social contract between science and society.
Getting serious about the challenge of regulating germline gene therapy
The announcement of He Jiankui's germline editing of human embryos has been followed by a torrent of almost universal criticism of the claim on scientific and ethical grounds, but a serious, rigorous framework must be imposed that insures that such research is done following the highest ethical standards.
Ordo-Responsibility for Germline Gene Editing.
The basic structure of an appropriate rule-finding process is explained, a possible pathway toward an international framework is outlined, and minimal requirements that are needed are discussed that contribute to the debate on how to govern genome-editing technologies and GGE globally.
Contesting the Geneticization Thesis in Human Reproduction: Dealing with Spiral Shaped Processes and Technoscientific Imaginaries
This paper questions the potential shift of reproduction towards assisted reproductive technologies due to benefits provided by genetic manipulation of embryos. In order to examine the viability of
Realigning gene editing with clinical research ethics: What the “CRISPR Twins” debacle means for Chinese and international research ethics governance
Commentary surrounding the question of the enforceability of Chinese regulations in the case of the "CRISPR babies" argues that Chinese regulations do align with internationally accepted standards.
Canada's Assisted Human Reproduction Act: Pragmatic Reforms in Support of Research
It is argued that the current regulation of research using human reproductive materials is not proportionate, not responsive to the uncertain threats posed to human and environmental health and safety, and is not considerate of diverse values in a democratic society.
Regulating reproductive genetic services: dealing with spiral-shaped processes and techno-scientific imaginaries
There is a ‘grey-zone’ of RGS regulations regarding four procedures: the use of germline genome modification (GGM) for severe monogenic disorders, preimplantation genetic testing (PGT) for detection of chromosomal abnormalities, PGT for multifactorial diseases, and PGT with whole-exome screening.


Disease Resistance and the Definition of Genetic Enhancement
An overview of the key ethical features of CCR5-Δ32 deletion is provided (including its frequency in various populations, biological mechanism, benefits for individuals, and use in previous clinical trials) to offer some potential guideposts for the continuing discussion on how to classify “enhancements” in the age of CRISPR gene editing.
Draft Ethical Principles for Therapeutic Assisted Reproductive Technologies
The identification of a core set of fundamental human values to frame, guide, and restrict clinical applications that communities around the world can share and localize based on religious beliefs, culture, and public-health challenges is proposed.
Should we edit the human germline? Is consensus possible or even desirable?
  • Hastings Center report
  • 2018
Should we edit the human germline? Is consensus possible or even desirable? Hastings Center report
  • https://www.thehastingscenter.org/edit-humangermline-consensus-possible-even-desirable
  • 2018
the case of the first gene-edited babies
  • The Conversation
  • 2018
Rogue science strikes again : the case of the first gene - edited babies
Rogue science strikes again: the case of the first gene-edited babies. The Conversation